These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 12927009)

  • 1. Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms.
    Chang KD; Dienes K; Blasey C; Adleman N; Ketter T; Steiner H
    J Clin Psychiatry; 2003 Aug; 64(8):936-42. PubMed ID: 12927009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE; Kowatch RA; Carmody T; Rush AJ
    Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder.
    DelBello MP; Adler CM; Whitsel RM; Stanford KE; Strakowski SM
    J Clin Psychiatry; 2007 May; 68(5):789-95. PubMed ID: 17503991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial.
    Muzina DJ; Gao K; Kemp DE; Khalife S; Ganocy SJ; Chan PK; Serrano MB; Conroy CM; Calabrese JR
    J Clin Psychiatry; 2011 Jun; 72(6):813-9. PubMed ID: 20816041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania.
    State RC; Frye MA; Altshuler LL; Strober M; DeAntonio M; Hwang S; Mintz J
    J Clin Psychiatry; 2004 Aug; 65(8):1057-63. PubMed ID: 15323589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divalproex sodium in substance abusers with mood disorder.
    Albanese MJ; Clodfelter RC; Khantzian EJ
    J Clin Psychiatry; 2000 Dec; 61(12):916-21. PubMed ID: 11206596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder.
    Bowden CL; Myers JE; Grossman F; Xie Y
    J Clin Psychiatry; 2004 May; 65(5):707-14. PubMed ID: 15163260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopathology in children of bipolar parents.
    Singh MK; DelBello MP; Stanford KE; Soutullo C; McDonough-Ryan P; McElroy SL; Strakowski SM
    J Affect Disord; 2007 Sep; 102(1-3):131-6. PubMed ID: 17275096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric Disorders and Quality of Life in the Offspring of Parents with Bipolar Disorder.
    Goetz M; Sebela A; Mohaplova M; Ceresnakova S; Ptacek R; Novak T
    J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):483-493. PubMed ID: 28581338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
    Hirschfeld RM; Bowden CL; Vigna NV; Wozniak P; Collins M
    J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes.
    Revicki DA; Paramore LC; Sommerville KW; Swann AC; Zajecka JM;
    J Clin Psychiatry; 2003 Mar; 64(3):288-94. PubMed ID: 12716270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.
    Bowden CL; Calabrese JR; McElroy SL; Gyulai L; Wassef A; Petty F; Pope HG; Chou JC; Keck PE; Rhodes LJ; Swann AC; Hirschfeld RM; Wozniak PJ
    Arch Gen Psychiatry; 2000 May; 57(5):481-9. PubMed ID: 10807488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome with divalproex in children and adolescents with bipolar disorder.
    Henry CA; Zamvil LS; Lam C; Rosenquist KJ; Ghaemi SN
    J Child Adolesc Psychopharmacol; 2003; 13(4):523-9. PubMed ID: 14977465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania.
    Bowden CL; Swann AC; Calabrese JR; Rubenfaer LM; Wozniak PJ; Collins MA; Abi-Saab W; Saltarelli M;
    J Clin Psychiatry; 2006 Oct; 67(10):1501-10. PubMed ID: 17107240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Emergent Course of Bipolar Disorder: Observations Over Two Decades From the Canadian High-Risk Offspring Cohort.
    Duffy A; Goodday S; Keown-Stoneman C; Grof P
    Am J Psychiatry; 2019 Sep; 176(9):720-729. PubMed ID: 30525908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
    Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
    J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.